Jing Lu
Impact in
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Immune cells in cancer
- Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
- Immunology 21
- Psoriasis: Treatment and Pathogenesis 12
- IL-33, ST2, and ILC Pathways 4
- Co-authors
- Liping Xia (33 shared papers)Hui Shen (20 shared papers)Hui Shen (7 shared papers)Weiguo Xiao (5 shared papers)Shuang Guan (7 shared papers)Ye Tian (2 shared papers)Xuming Deng (4 shared papers)Meixia Huo (3 shared papers)
- Journals
- Journal of Investigative Medicine (6 papers)Journal of Interferon & Cytokine Research (6 papers)Cytokine (6 papers)International Immunopharmacology (4 papers)Scandinavian Journal of Rheumatology (3 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Jing Lu
80 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 113
- Immunology 553
- Rheumatology 342
- Dermatology 93
- Pharmacology 84
- Oncology 238
Countries citing papers authored by Jing Lu
This map shows the geographic impact of Jing Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lu more than expected).
Fields of papers citing papers by Jing Lu
This network shows the impact of papers produced by Jing Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lu. The network helps show where Jing Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 126 | |
| 2 | 2012 | 97 | |
| 3 | 2013 | 82 | |
| 4 | 2012 | 65 | |
| 5 | 2011 | 62 | |
| 6 | 2015 | 53 | |
| 7 | 2012 | 46 | |
| 8 | 1999 | 41 | |
| 9 | 2003 | 41 | |
| 10 | 2015 | 39 | |
| 11 | 2018 | 32 | |
| 12 | 2011 | 31 | |
| 13 | 2014 | 29 | |
| 14 | 2019 | 29 | |
| 15 | 2010 | 29 | |
| 16 | 2010 | 29 | |
| 17 | 2011 | 29 | |
| 18 | 2010 | 29 | |
| 19 | 2013 | 27 | |
| 20 | 2021 | 26 |
About Jing Lu
Jing Lu is a scholar working on Immunology, Molecular Biology, Rheumatology, Dermatology and Oncology, having authored 84 papers that have together received 1.6k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (13 papers), Psoriasis: Treatment and Pathogenesis (12 papers), Dermatology and Skin Diseases (8 papers), Autoimmune and Inflammatory Disorders Research (7 papers), Systemic Lupus Erythematosus Research (6 papers), Cytokine Signaling Pathways and Interactions (5 papers), IL-33, ST2, and ILC Pathways (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). The work is most often cited by research in Immunology (553 citations), Rheumatology (342 citations), Dermatology (93 citations), Pharmacology (84 citations) and Oncology (238 citations). Jing Lu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Liping Xia, Hui Shen, Hui Shen, Weiguo Xiao, Shuang Guan, Ye Tian, Xuming Deng, Meixia Huo, Duochuan Li and Bocui Song. Their work appears in journals such as Journal of Investigative Medicine, Journal of Interferon & Cytokine Research, Cytokine, International Immunopharmacology and Scandinavian Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.